Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Gilead Sciences Inc Q2 Adjusted EPS USD -6.75 Vs. IBES Estimate USD -7.24

BRIEF-Gilead Sciences Inc Q2 Adjusted EPS USD -6.75 Vs. IBES Estimate USD -7.24

ReutersReuters2026/08/04 20:02

Aug 04 (Reuters) - Gilead Sciences Inc Q2 product sales USD 7,627 million.

  • Q2 net income USD -10,496 million
  • Q2 EPS USD -8.45
  • Outlook FY adjusted EPS USD -0.65 to -0.3
  • Outlook FY product sales USD 30,100-30,400 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!